132 related articles for article (PubMed ID: 25277657)
1. Rrp1B gene polymorphism (1307T>C) in metastatic progression of breast cancer.
Nanchari SR; Cingeetham A; Meka P; Damineni S; Tipirisetti N; Padala C; Annamaneni S; Rani Hanumanth S; Digumarthi RR; Satti V
Tumour Biol; 2015 Feb; 36(2):615-21. PubMed ID: 25277657
[TBL] [Abstract][Full Text] [Related]
2. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.
Crawford NP; Qian X; Ziogas A; Papageorge AG; Boersma BJ; Walker RC; Lukes L; Rowe WL; Zhang J; Ambs S; Lowy DR; Anton-Culver H; Hunter KW
PLoS Genet; 2007 Nov; 3(11):e214. PubMed ID: 18081427
[TBL] [Abstract][Full Text] [Related]
3. The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.
Ugenskienė R; Myrzaliyeva D; Jankauskaitė R; Gedminaitė J; Jančiauskienė R; Šepetauskienė E; Juozaitytė E
Biomarkers; 2016; 21(4):363-70. PubMed ID: 26901824
[TBL] [Abstract][Full Text] [Related]
4. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.
Hsieh SM; Look MP; Sieuwerts AM; Foekens JA; Hunter KW
Breast Cancer Res; 2009; 11(5):R75. PubMed ID: 19825179
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-associated protein ribosomal RNA processing 1 homolog B (RRP1B) modulates metastasis through regulation of histone methylation.
Lee M; Dworkin AM; Lichtenberg J; Patel SJ; Trivedi NS; Gildea D; Bodine DM; Crawford NP
Mol Cancer Res; 2014 Dec; 12(12):1818-28. PubMed ID: 25092915
[TBL] [Abstract][Full Text] [Related]
6. The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.
Crawford NP; Yang H; Mattaini KR; Hunter KW
J Biol Chem; 2009 Oct; 284(42):28660-73. PubMed ID: 19710015
[TBL] [Abstract][Full Text] [Related]
7. RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1.
Lee M; Dworkin AM; Gildea D; Trivedi NS; ; Moorhead GB; Crawford NP
Oncogene; 2014 Apr; 33(14):1818-27. PubMed ID: 23604122
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
Hsieh SM; Smith RA; Lintell NA; Hunter KW; Griffiths LR
BMC Cancer; 2009 Sep; 9():331. PubMed ID: 19765277
[TBL] [Abstract][Full Text] [Related]
9. Involvement of microRNA-423 Gene Variability in Breast Cancer Progression in Saudi Arabia.
Mir R; Al Balawi IA; Duhier FMA
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2581-2589. PubMed ID: 30256064
[TBL] [Abstract][Full Text] [Related]
10. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
11. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
[TBL] [Abstract][Full Text] [Related]
12. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
13. [Association of CYP19A1 gene rs7176005 single nucleotide polymorphism with breast cancer risk and clinicopathologic features of tumor].
Du ZG; Wang LY; Zhou Y; Wan HY; Liang FQ; Lyu Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):827-832. PubMed ID: 30107717
[No Abstract] [Full Text] [Related]
14. The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.
Crawford NP; Walker RC; Lukes L; Officewala JS; Williams RW; Hunter KW
Clin Exp Metastasis; 2008; 25(4):357-69. PubMed ID: 18301994
[TBL] [Abstract][Full Text] [Related]
15. Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor.
Pal R; Gochhait S; Chattopadhyay S; Gupta P; Prakash N; Agarwal G; Chaturvedi A; Husain N; Husain SA; Bamezai RN
Breast Cancer Res Treat; 2011 Apr; 126(2):333-43. PubMed ID: 20443055
[TBL] [Abstract][Full Text] [Related]
16. Genetic Effects of Vascular Endothelial Growth Factor A (VEGF-A) and Its Association with Disease Progression in Breast Cancer Population of Saudi Arabia.
Albalawi IA; Mir R; Abu Duhier FM
Asian Pac J Cancer Prev; 2020 Jan; 21(1):139-145. PubMed ID: 31983176
[TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
19. ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study.
Xu F; Li D; Zhang Q; Fu Z; Zhang J; Yuan W; Chen S; Pang D; Li D
BMC Cancer; 2011 Sep; 11():392. PubMed ID: 21917182
[TBL] [Abstract][Full Text] [Related]
20. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
